BERGER FRANKLIN M 4/A
4/A · Atea Pharmaceuticals, Inc. · Filed Jan 17, 2025
Insider Transaction Report
Form 4/AAmended
BERGER FRANKLIN M
Director
Transactions
- Purchase
Common Stock
2025-01-15$3.19/sh+15,000$47,885→ 466,897 total - Purchase
Common Stock
2025-01-16$3.36/sh+10,000$33,614→ 476,897 total
Footnotes (3)
- [F1]This Form 4/A has been filed solely to change the code reported in Column 4 of Table I of the Reporting Person's Form 4 filed on January 17, 2025, which had inadvertently noted a "D" instead of "A" to reflect an acquisition of the common stock of Atea Pharmaceuticals, Inc. (the "Company"), due to an administrative error.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.165 to $3.21. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.32 to $3.405. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.